• Explore /
  • Poster
  • / Next Generation Sequencing (NGS) to reveal mutations in IDH1 and its effect on patient (pt) outcomes in advanced biliary tract cancer (aBTC) who received gemcitabine and cisplatin (GC).

Next Generation Sequencing (NGS) to reveal mutations in IDH1 and its effect on patient (pt) outcomes in advanced biliary tract cancer (aBTC) who received gemcitabine and cisplatin (GC).

Abstract Poster

Authors

null

Daniel H. Ahn

The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital, Richard J. Solove Research Institute, Columbus, OH

Daniel H. Ahn , Chul Ahn , Apurva Jain , Sameh Mikhail , Christina Sing-Ying Wu , Richard M. Goldberg , Kristen Keon Ciombor , Anne M. Noonan , Priyanka Sadavartia , Rachna T. Shroff , Milind M. Javle , James Lin Chen , Tanios S. Bekaii-Saab

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 287)

DOI

10.1200/jco.2016.34.4_suppl.287

Abstract #

287

Poster Bd #

E11

Abstract Disclosures

Similar Posters

First Author: John Ebben

First Author: Richard D. Kim

First Author: Li Jingjing

First Author: Vaibhav Sahai